Hikma Tells Justices Cox Ruling Boosts 'Skinny Label' Case

By Ryan Davis · April 13, 2026, 8:01 PM EDT

Hikma Pharmaceuticals USA Inc. told the U.S. Supreme Court on Monday that the justices' recent decision clearing an internet company in a copyright case bolsters the drugmaker's challenge to a patent...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Reply

Case Information

Case Title

Hikma Pharmaceuticals USA Inc., et al., Petitioners v. Amarin Pharma, Inc., et al.

Case Number

Court

Supreme Court

Nature of Suit

830 Patent Infringement (Fed. Qst.)

Date Filed

February 19, 2025

Recent Articles By Ryan

March 30, 2026
Don't Set Special IP Rules For 'Skinny Labels,' Justices Told
March 23, 2026
Amarin Tells Justices Hikma Drug Patent Appeal Threatens IP
March 19, 2026
Apple Watch Redesign Gets Early OK As Patent Loss Upheld
March 10, 2026
Justices Advised To Keep Law Clear In 'Skinny Label' Case
February 26, 2026
Justices Told 'Skinny Label' Case Puts Generic Drugs At Risk
January 20, 2026
Justices To Clarify What's Fair Game With 'Skinny Labels'
January 16, 2026
Supreme Court Takes On Hikma's 'Skinny Label' Patent Case
December 23, 2025
Justices Urged To Spurn SG's Call To Tackle 'Skinny Labels'
December 19, 2025
Squires Issues 21 More Patent Review Denials
December 10, 2025
Apple Tells Fed. Circ. ITC Move Boosts Watch Case Appeal